Results 31 to 40 of about 5,551,076 (177)

Mycoplasma pneumoniae: Atypical Pathogen in Community Acquired Pneumonia

Journal of Pure and Applied Microbiology, 2020
Mycoplasma pneumoniae is a one of most common reasons of respiratory tract infections in both adolescents and children with severity ranged from moderate to high. Many facts in the previous years regarding infections were induced via this organism having
Abdul-Rahman Mamdouh Mohammad, Rehab Mahmoud Abd El-Baky, Eman Farouk Ahmed   +2 more
doaj   +1 more source

Community-acquired pneumonia [PDF]

Current Opinion in Pulmonary Medicine, 2003
Community-acquired pneumonia (CAP) remains an important cause of morbidity and mortality. Streptococcus pneumoniae is the most common pathogen and respiratory syncitial virus the most important viral pathogen in children. The role of urinary antigen testing and PCR for the diagnosis forS.
Julie, Andrews, Behzad, Nadjm, Vanya, Gant, Nandini, Shetty   +3 more
openaire   +4 more sources

A Comparison of Bacteremic Pneumococcal Pneumonia with Nonbacteremic Community-Acquired Pneumonia of Any Etiology — Results from a Canadian Multicenter Study

Canadian Respiratory Journal, 2003
BACKGROUND: Bacteremic pneumococcal pneumonia has not been the subject of a multicentre Canadian Study.
Thomas J Marrie, Donald E Low, Emidio de Carolis, the Canadian Community-Acquired Pneumonia Investigators   +3 more
doaj   +1 more source

Adjuvant Inhaled Corticosteroids in Community-Acquired Pneumonia: A Review Article

Medical Sciences, 2021
Community-acquired pneumonia is still a major cause of morbidity and mortality worldwide. Since the inflammatory response induced by the immune system is often a major contributor to the lung injury, it becomes reasonable to assess the potential benefit ...
Faeq R. Kukhon, Emir Festic
doaj   +1 more source

Clinical Comparative Study of Sulbactam/Ampicillin and Imipenem/Cilastatin in Elderly Patients with Community-Acquired Pneumonia [PDF]

, 2006
Objective: To evaluate the clinical usefulness of sulbactam/ampicillin therapy for community-acquired pneumonia in the elderly. Methodology: A randomized prospective clinical study was conducted in the elderly patients with moderate-to-severe community ...
Higashiyama, Yasuhito, Mizuta, Yohei, Yanagihara, Katsunori, Miyazaki, Yoshitsugu, Kohno, Shigeru, Fukuda, Yuichi, Izumikawa, Koichi, Tomono, Kazunori, Hirakata, Yoichi, Tsukamoto, Kazuhiro, Seki, Masafumi   +10 more
core   +1 more source

Legionnaires' Disease - Results of a Multicenter Canadian Study

Canadian Journal of Infectious Diseases, 2003
BACKGROUND: There has never been a cross-Canada surveillance project to determine the rate of Legionella species as a cause of community-acquired pneumonia requiring hospitalization and to determine whether there are any regional differences in the rates
Thomas J Marrie, Emidio de Carolis, Victor L Yu, Janet Stout, the Canadian Community-Acquired Pneumonia Investigators   +4 more
doaj   +1 more source

New Perspective in Treatment of Community-Acquired Pneumonia

, 2022
Pneumonia has been one of the top contenders for the leading cause of death for decades. Due to vague symptoms and unreliable laboratory examinations, treatment of community-acquired pneumonia relies on empiric use of antibiotics more than any other ...
Cheng, Yu-Fan
core   +1 more source

ETIOLOGICAL FEATURES AND ANTIMICROBIAL RESISTANCE IN HEALTHCARE-ASSOCIATED PNEUMONIA

Arta Medica, 2020
Objectives. Healthcare-associated pneumonia develops in patients undergoing regular medical procedures or has a longterm contact with the hospital environment. Several studies have shown important differences in healthcare-associated pneumonia, comparing
Cristina Toma, Doina Rusu, Victor Botnaru   +2 more
doaj   +1 more source

Community acquired pneumonia [PDF]

Archives of Disease in Childhood, 2001
We live in an era when medical practice is increasingly regulated by guidelines and protocols. Ideally, such guidance should be evidence based, and in particular it is generally recommended that advice on medical treatment should be based on the results of adequately powered, double blind, placebo controlled trials or, some would say, better still, a ...
openaire   +2 more sources

The pneumonia severity index predicts time to clinical stability in patients with community-acquired pneumonia

, 2006
SETTING: A total of 33 hospitals in 13 countries in North America, Europe, Africa, Asia and Latin America. OBJECTIVE: To investigate the relationship between the pneumonia severity index (PSI) and the time to clinical stability from intravenous to oral ...
A. LaJoie, J. Roig, J. Ramirez, J. Rello, P. Rossi, Community Acquired Pneumonia Organization, E. Rodriguez, P. Fernandez, T. Marrie, K. Weiss, G. Levy, F. Blasi, C. Luna, C. Feldman, J. Porras, F. Arnold, F. Arteta   +16 more
core   +2 more sources